Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS??? EQUITY

v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2020 [1]   37,200,000      
Beginning balance at Dec. 31, 2020 [1] $ 39,195 $ 4 $ 53,059 $ (14,374) $ 506
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Parent’s contributions 2,110   2,110    
Foreign currency translation, net of tax (179)       (179)
Net income (loss) (23,575)     (23,575)  
Ending balance (in shares) at Jun. 30, 2021 [1]   37,200,000      
Ending balance at Jun. 30, 2021 [1] 17,551 $ 4 55,169 (37,949) 327
Beginning balance (in shares) at Mar. 31, 2021 [1]   37,200,000      
Beginning balance at Mar. 31, 2021 [1] 33,400 $ 4 55,169 (22,048) 275
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Foreign currency translation, net of tax 52       52
Net income (loss) (15,901)     (15,901)  
Ending balance (in shares) at Jun. 30, 2021 [1]   37,200,000      
Ending balance at Jun. 30, 2021 [1] 17,551 $ 4 55,169 (37,949) 327
Beginning balance (in shares) at Dec. 31, 2021   62,690,869      
Beginning balance at Dec. 31, 2021 107,222 $ 6 183,024 (75,911) 103
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Equity-based compensation expense 6,154   6,154    
Common stock issued under the committed equity facility (in shares)   310,815      
Common stock issued under the committed equity facility 1,260   1,260    
Committed equity facility fee settled in common stock (in shares)   127,751      
Committed equity facility fee settled in common stock 756   756    
Foreign currency translation, net of tax (486)       (486)
Net income (loss) (94,321)     (94,321)  
Other (in shares)   124,401      
Other 513   513    
Ending balance (in shares) at Jun. 30, 2022   63,253,836      
Ending balance at Jun. 30, 2022 21,098 $ 6 191,707 (170,232) (383)
Beginning balance (in shares) at Mar. 31, 2022   62,690,869      
Beginning balance at Mar. 31, 2022 94,212 $ 6 187,435 (93,204) (25)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Equity-based compensation expense 1,743   1,743    
Common stock issued under the committed equity facility (in shares)   310,815      
Common stock issued under the committed equity facility 1,260   1,260    
Committed equity facility fee settled in common stock (in shares)   127,751      
Committed equity facility fee settled in common stock 756   756    
Foreign currency translation, net of tax (358)       (358)
Net income (loss) (77,028)     (77,028)  
Other (in shares)   124,401      
Other 513   513    
Ending balance (in shares) at Jun. 30, 2022   63,253,836      
Ending balance at Jun. 30, 2022 $ 21,098 $ 6 $ 191,707 $ (170,232) $ (383)
[1] The units of the Company prior to the Merger (as defined in Note A) have been retroactively restated to reflect the exchange ratio established in the Merger (computed as 37,200,000 shares of common stock to 100 Company units).